At 9:50AM, the 30-share Sensex was up 28 points at 27,140 and the 50-share Nifty was up 12 points at 8,127.
Foreign funds sold shares worth Rs 9.5 crore on Thursday, as per provisional stock exchange data.
Also Read
Asian shares firmed on the back of encouraging reports on the initial public offering by Chinese e-commerce major Alibaba Group. Shares in Japan were trading higher as the yen weakened against the US dollar. The benchmark Nikkei was up 1.4% at 16,301. The Shanghai Composite and Hang Seng were trading flat with positive bias while Straits Times was up 0.3%.
TCS was the top Sensex gainer up nearly 2% followed by HDFC, Sun Pharma, Bajaj Auto and ONGC among others.
Cipla was up 1.5% after it signed an agreement with American company Salix Pharmaceuticals, under which Cipla has granted Salix exclusive rights over certain patent applications in the 'Rifaximin Complexes' patents owned by Cipla. The grant is on a worldwide basis, excluding the countries of Asia (other than Japan) and Africa.
Among other shares, Biocon is trading higher by 2.5% at Rs 512, after the biotechnology firm said Silver Leaf Oak acquires 10% stake in Syngene International, the company’s research services subsidiary. Silver Leaf Oak (Mauritius), an investment vehicle advised by India Value Fund Advisors (IVFA), has agreed to acquire a minority 10% stake in Syngene, the research services subsidiary of Biocon, the company said in a statement.
The broader market also trimmed some of the early gains and the BSE Mid-cap and Small-cap indices were up 0.6% each.
Market breadth was strong with 1,294 gainers and 654 losers on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)